These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
128 related articles for article (PubMed ID: 9265075)
1. Selection and adaptation of cells expressing major histocompatibility complex class I-specific receptors of the natural killer complex. Bendelac A J Exp Med; 1997 Aug; 186(3):349-51. PubMed ID: 9265075 [No Abstract] [Full Text] [Related]
2. Inhibitory and activatory receptors for HLA class I molecules in human natural killer cells. Moretta A; Vitale M; Sivori S; Morelli L; Pende D; Bottino C Chem Immunol; 1996; 64():77-87. PubMed ID: 8942073 [No Abstract] [Full Text] [Related]
3. Events in the adaptation of natural killer cell receptors to MHC class I polymorphisms. Parham P Res Immunol; 1997; 148(3):190-4. PubMed ID: 9255873 [No Abstract] [Full Text] [Related]
4. NK-cell receptors and recognition of MHC class I molecules. López-Botet M; Moretta L; Strominger J Immunol Today; 1996 May; 17(5):212-4. PubMed ID: 8991381 [TBL] [Abstract][Full Text] [Related]
5. Expression of HLA class I-specific inhibitory receptors by chronically activated cytolytic T lymphocytes: useful or harmful to the host? Mingari MC; Ponte M; Vitale C; Schiavetti F; Bertone S; Moretta L Melanoma Res; 1997 Aug; 7 Suppl 2():S89-93. PubMed ID: 9578422 [TBL] [Abstract][Full Text] [Related]
6. Immunoglobulin superfamily inhibitory receptors: from natural killer cells to antigen-presenting cells. Colonna M Res Immunol; 1997; 148(3):169-71. PubMed ID: 9255869 [No Abstract] [Full Text] [Related]
7. Regulation of class I major histocompatibility complex receptor expression in natural killer cells: one promoter is not enough! Pascal V; Stulberg MJ; Anderson SK Immunol Rev; 2006 Dec; 214():9-21. PubMed ID: 17100872 [TBL] [Abstract][Full Text] [Related]
8. Control of self-reactive cytotoxic T lymphocytes expressing gamma delta T cell receptors by natural killer inhibitory receptors. Halary F; Peyrat MA; Champagne E; Lopez-Botet M; Moretta A; Moretta L; Vié H; Fournié JJ; Bonneville M Eur J Immunol; 1997 Nov; 27(11):2812-21. PubMed ID: 9394804 [TBL] [Abstract][Full Text] [Related]
9. Stochastic acquisition of Qa1 receptors during the development of fetal NK cells in vitro accounts in part but not in whole for the ability of these cells to distinguish between class I-sufficient and class I-deficient targets. Toomey JA; Salcedo M; Cotterill LA; Millrain MM; Chrzanowska-Lightowlers Z; Lawry J; Fraser K; Gays F; Robinson JH; Shrestha S; Dyson PJ; Brooks CG J Immunol; 1999 Sep; 163(6):3176-84. PubMed ID: 10477585 [TBL] [Abstract][Full Text] [Related]
10. Human natural killer cell inhibitory receptors bind to HLA class I molecules. Döhring C; Colonna M Eur J Immunol; 1996 Feb; 26(2):365-9. PubMed ID: 8617305 [TBL] [Abstract][Full Text] [Related]
11. Major histocompatibility complex class I-dependent skewing of the natural killer cell Ly49 receptor repertoire. Held W; Dorfman JR; Wu MF; Raulet DH Eur J Immunol; 1996 Oct; 26(10):2286-92. PubMed ID: 8898935 [TBL] [Abstract][Full Text] [Related]
12. Interleukin-15-induced maturation of human natural killer cells from early thymic precursors: selective expression of CD94/NKG2-A as the only HLA class I-specific inhibitory receptor. Mingari MC; Vitale C; Cantoni C; Bellomo R; Ponte M; Schiavetti F; Bertone S; Moretta A; Moretta L Eur J Immunol; 1997 Jun; 27(6):1374-80. PubMed ID: 9209487 [TBL] [Abstract][Full Text] [Related]
13. HLA class-I-specific inhibitory receptor in human T lymphocytes: interference with T-cell functions. Mingari MC; Ponte M; Vitale C; Schiavetti F; Bellomo R; Bertone S; Nanni L Res Immunol; 1997; 148(3):150-5. PubMed ID: 9255865 [No Abstract] [Full Text] [Related]
14. Altered phenotype and function of natural killer cells expressing the major histocompatibility complex receptor Ly-49 in mice transgenic for its ligand. Olsson MY; Kärre K; Sentman CL Proc Natl Acad Sci U S A; 1995 Feb; 92(5):1649-53. PubMed ID: 7878033 [TBL] [Abstract][Full Text] [Related]
15. Having it both ways: MHC recognition in cis and trans. Leibson PJ; Pease LR Nat Immunol; 2004 Mar; 5(3):237-8. PubMed ID: 14985707 [No Abstract] [Full Text] [Related]
16. Taking license with natural killer cell maturation and repertoire development. Parham P Immunol Rev; 2006 Dec; 214():155-60. PubMed ID: 17100883 [TBL] [Abstract][Full Text] [Related]
17. MHC and MHC-related proteins as pleiotropic signal molecules. Ojcius DM; Delarbre C; Kourilsky P; Gachelin G FASEB J; 2002 Feb; 16(2):202-6. PubMed ID: 11818368 [TBL] [Abstract][Full Text] [Related]
18. The human natural killer lymphocyte receptors for MHC class I molecules. Bensussan A Eur Cytokine Netw; 1998 Dec; 9(4):577-83. PubMed ID: 9889401 [No Abstract] [Full Text] [Related]
19. Natural killer cell receptors specific for major histocompatibility complex class I molecules. Yokoyama WM Proc Natl Acad Sci U S A; 1995 Apr; 92(8):3081-5. PubMed ID: 7724519 [No Abstract] [Full Text] [Related]
20. Human T-cell leukemia virus type 1 (HTLV-1) p12I down-modulates ICAM-1 and -2 and reduces adherence of natural killer cells, thereby protecting HTLV-1-infected primary CD4+ T cells from autologous natural killer cell-mediated cytotoxicity despite the reduction of major histocompatibility complex class I molecules on infected cells. Banerjee P; Feuer G; Barker E J Virol; 2007 Sep; 81(18):9707-17. PubMed ID: 17609265 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]